Addressing Access to Care: Understanding Federal and State Issues Part 1: A Basic Guide for Advocates
Launch Viewer to Begin
PDFLRI 12.4.2013 Ppt. Slides (1 Per Page).pdf
PDFLRI 12.4.2013 Ppt. Slides (3 Per Page).pdf
MP4Addressing Access to Care: Understanding Federal and State Issues - Part 1: A Basic Guide for Advoca
The Lupus Research Institute (LRI) is the world’s leading private supporter of innovative research in lupus and a strong advocate for federal support of lupus research among members of Congress, health groups, the pharmaceutical industry, and the public. The LRI’s advocacy arm is its National Coalition, a powerful network of state and local lupus organizations united to prevent, treat and cure lupus by advocating for lupus on Capitol Hill. The LRI advocates for lasting change in numerous ways. We need people with lupus and those impacted by lupus to let their voice be heard in order to improve access to care for people with lupus and other debilitating chronic illnesses.

This webinar, the first of a three part series, will cover advocacy basics such as how Congress works, how a bill becomes a law, the budget and appropriations process, and how to work with members of Congress. The information presented in this webinar will help you on the way to becoming an effective advocate and will let you know how you can work with the LRI and National Coalition members to strengthen the voice of people with lupus.


  • To understand at what stages in the process it is important to be involved
  • To learn how to communicate with and engage members of Congress
  • To understand how to look up and track the progress of a bill

Who Should Attend:
  • People interested in becoming advocates for access to care issues
  • Seasoned advocates who need a refresher


This webinar is for educational and informational purposes. The information provided here should not be used for the purposes of diagnosing or treating a medical illness. It is not intended to be a substitute for professional care. Lupus is a very individualized illness; consult with a healthcare professional, in-person, before making any decisions about your care. The Lupus Research Institute and S.L.E. Lupus Foundation employees, consultants, and agents shall not be liable for any claims or damages, and expressly disclaim all liability of any nature for any action or non-action taken as a result of the information generated by sponsored programs.
Seminar Information
Seminar Date:
December 04, 2013